Casasnovas, C., Pujol, A., et. al. (2019). Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study. Neurotherapeutics, 16(4), 1167-1182. https://t.co/1uqbGUcKpA
241 followers
420 followers
Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy (AMN): a Phase II Pilot Study https://t.co/1OeZFl8c6U
5,107 followers
RT @craibiologia: 🔬 "Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot S…
1,430 followers
🔬 "Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study", Francesc Villarroya, Aurora Pujol, Carlos Casasnovas et al. #RecercaCRAIBiologiaUB 👉Article: https://t.co/twFDGAEzvF (open acce